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Abstract 
Purpose: To investigate the diuretic potentials of naringenin (NGN) in obesity induced in rats by high fat 
diet (HFD). 
Methods: To prepare HFD, normal pellet diet was crushed and thoroughly mixed with cholesterol 
powder (1 % w/w). The mixture was mixed with some water and made into pellets which were then 
oven-baked to dry. Four groups of male Wistar albino rats (n = 6) were used for the study. Normal 
control (group I) received normal pellet diet. Group 2 (HFD-only) was fed HFD for 28 days, while Groups 
3 and 4 were co-administered HFD and NGN at doses of 50 and 100 mg/kg, respectively. All treatments 
were given orally, and lasted for 28 days. Twenty-four hours after the last dose of NGN, blood was 
collected from all rats and total cholesterol levels determined to confirm obesity. Thereafter, the rats 
were placed in metabolic cages and urine samples were collected at two time-points (5 and 24 h) for 
measurement of urine volume, urinary pH, conductivity and electrolyte levels (Na, K and Cl). 
Results: Treatment with HFD resulted in significantly (p < 0.05) increased serum cholesterol level 
(178.83 ± 5.43 mg/dL) when compared to normal control rats (88.17 ± 4.04 mg/dL). It also led to 
decrease in urinary volume (~50 %) at both time points (5 and 24 h) and in excretion of urinary 
electrolytes (sodium, potassium and chloride ions). However, the changes in these parameters were 
significantly reversed by NGN administration (p < 0.05). 
Conclusion: These results demonstrate the diuretic activity of NGN in HFD-induced obese rats. Thus, 
NGN can be further explored for use in combination with hypolipidemic agents to tackle obesity. 
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 Epidemiologic data have shown that Western-
style dietary patterns play a major role in the 
development of diabetes mellitus, hyperlipidemia 
and disorders of the cardiovascular system [1,2]. 
Studies have demonstrated a link between HFD 
and the etiology of hypertension, obesity and 
hyperlipidemia [3]. There are high chances of 
acute renal dysfunction from fluid shifts and 
hypovolemia in obese patients with BMI more 
than 60 kg/m2.  In addition, obesity is associated 
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with significant decreases in urine output.  Many 
types of drugs have been effectively used for the 
treatment of these clinical disorders, but the 
unwanted side effects of these agents limit their 
applications. The established lipid lowering drugs 
such as fibrates, statins and bile acid-binding 
resins have many side effects [4]. Therefore, 
there is a growing interest in the development of 
lipid-lowering drugs with diuretic activities from 
natural products for the treatment of obesity. 
 
Daily intake of fruits and vegetables could be 
beneficial in the treatment of chronic diseases 
that make up metabolic syndrome [5,6]. Several 
studies have demonstrated the potential health 
benefits of flavonoids and anthocyanins against 
the various disorders associated with metabolic 
syndrome [7]. Citrus fruits are rich in flavonoids, 
the most predominant of which is naringenin (4’, 
5, 7-trihydroxyflavanone; NGN), a flavanone [8]. 
Studies have demonstrated that NGN possesses 
anticancer [9], lipid-lowering [10], anti-
atherogenic [11] and antioxidant [12] properties.  
 
The aim of the present study was to investigate 
the diuretic effect of NGN on HFD-induced 




Reagents and chemicals 
 
Naringenin powder and total cholesterol kit were 
products of Sigma–Aldrich Chemical Co., USA. 
The NGN doses used in this study were based 




Mature, male albino rats (Wistar strain) weighing 
180-200g were supplied by the Animal Care Unit 
of College of Pharmacy, Prince Sattam bin 
Abdulaziz University, KSA. The rats were 
acclimatized for 7 days under standard 
laboratory conditions in an environment with 12h 
light/12h dark cycle Standard pellet diet and 
water were made available to the rats ad libitum. 
The study was approved by the Ethical Review 
Committee, College of Pharmacy, Prince Sattam 
Bin Abdulaziz University, KSA (approval ref no. 
HAP-01-KJ-050). The experimental procedures 
were performed according to the guiding 
principles of the Institute for Laboratory Animal 
Research in Guide for the Care and Use of 
Laboratory Animals [14]. 
 
Preparation of cholesterol-supplemented diet  
 
Normal pellet diet was ground and mixed 
thoroughly with cholesterol powder (1% w/w). 
The resultant mixture was mixed with water and 
made into pellets which were then oven-baked 
for proper drying to avoid fungal contamination. 
 
Induction of obesity 
 
Normal Wistar rats were fed with the mixed pellet 




Four groups of Wistar albino rats were used (6 
rats per group). The assignment of rats to groups 
was done randomly. Rats in group 1 (normal 
control) received normal pellet diet only, while 
group 2 rats were fed HFD only. Groups 3 and 4 
were fed HFD co-administered with NGN at 
doses of 50 and 100 mg/kg, respectively. All 
treatments lasted for 28 days. Twenty-four hours 
after the last NGN dose, blood was withdrawn 
from retro-orbital plexus for the estimation of 
serum cholesterol level. Subsequently, urine 
samples were collected at two time points (5 and 
24 h) from the rats put in metabolism cages for 
24h. The 24h urine samples were filtered at the 
time of urine collection and used for 
determination of urinary pH and conductivity. The 
remaining urine samples were stored at −20 °C 
and used for analyses of electrolytes (Na+, K+ 
and Cl-). 
 
Evaluation of urine parameters 
 
Urinary conductivity was determined using 
Jenway conductivity meter (Jenway, UK), while 
urinary pH was measured using a pH meter 
(Hanna Instruments, Lynnfield, MA). The 24 h 
samples were then diluted (1:1000 in deionized 
water) and evaluated levels of K+, Na+ and Cl_ 
using Professional Ion Chromatography 
(Metrohm, Switzerland). 
 
Determination of saluretic activity, natriuretic 
activity and carbonic anhydrase inhibitory 
(CAI) activity 
 
Saluretic activity was measured by simply 
summing up the concentrations of Na+ and K+ 
present in the urine samples of each group. 
Natriuretic activity was measured by calculating 
the ratio of Na+ and K+ ion concentrations in the 
urine samples, while CAI activity was estimated 
by calculating the ratio: Cl-/ (Na+ + K+) [15]. 
 
Statistical analysis  
 
Data are expressed as mean ± SEM, and were 
analyzed by one-way ANOVA, followed by 
Dunnett's post hoc test for determination of inter-
group variability using SPSS program (version 21 
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software package; SPSS Inc, USA). Values of p 





Effect of NGN on serum total cholesterol 
levels 
 
After feeding normal healthy rats with HFD, there 
were significant increases in serum total 
cholesterol levels in all the rats (p < 0.05). 
However, the HFD-induced increases in serum 
total cholesterol in the obese rats were 
significantly decreased (p < 0.05) by NGN 




Figure 1: Total cholesterol level (mg/dL) of rats with 
HFD-induced experimental obesity. Values represent 
mean ± SEM of six rats for each group;*p < 0.05, 
relative to control group (n = 6); #p < 0.05, relative to 
HFD-only group 
 
Effect of NGN on urine output and diuretic 
activity 
 
The results of urine volume analysis are 
presented in Table 1. Obesity induced by HFD 
resulted in significant decreases in urine volume 
at both time points of sample collection i.e. 5h 
and 24h, relative to normal control (p < 0.05). 
Treatment with NGN at doses of 50 and 100 
mg/kg resulted in significant increases in urine 
volume, when compared to the obese rats, 
showing the diuretic effect of NGN. 
 
Effect of NGN on urinary pH and conductivity 
 
Results of urinary pH and conductivity are 
presented in Table 2. There was a decrease in 
the urinary pH of the obese rats (HFD only) when 
compared to urinary pH of control rats. However, 
NGN treatment resulted in increased urinary pH, 
although the increases were not statistically 
significant. The conductivity of the urine samples 
from the obese rats was significantly decreased, 
but was significantly increased by NGN treatment 
at the two dose levels. 
 
Table 1: Effect of NGN on urine volume and diuretic 
index in normal and obese rats 
 











CON  1.04±0.10 1.00 6.74±0.41 1.00 
HFD 
only 










2.28±0.17# 2.19 16.12±1.09# 2.39 
Values represent mean ± SEM (n = 6). Index = 
excretion in test group / excretion in control group. 
*Significantly different, when compared with control 
group (p < 0.05); #significantly different, when 
compared with HFD-only group (p < 0.05) 
 
Table 2: Effect of NGN on urinary pH and conductivity 
in normal and obese rats 
 
Group pH Conductivity 
Control  7.32 ± 0.07 11.87 ± 0.73 
HFD only 6.42 ± 0.09 6.92 ± 0.59* 
HFD + NGN (50 
mg/kg)  
8.07 ± 0.10 13.89 ± 0.75# 
HFD + NGN (100 
mg/kg)  
8.14 ± 0.12 15.82 ± 0.77# 
Values are mean ± SEM (n = 6). *Significantly 
different, relative to control group (p < 0.05); 
#significantly different, relative to HFD-only group (p < 
0.05). 
 
Effect of NGN on urinary electrolyte excretion 
 
Table 3 shows the urinary electrolyte content of 
the HFD-only, NGN-treated (50 and 100 mg/kg) 
and control rats. Excretion of urinary electrolytes 
(Na+, K+ and Cl-) was significantly lowered in the 
obese rats after exposure to HFD, when 
compared to control rats. The two doses of NGN 
(50 and 100 mg/kg) resulted in significant 
increases in urinary electrolyte excretion, relative 
to the HFD-only group (p < 0.05). 
 
Effect of NGN on natriuretic activity, saluretic 
activity and CAI activity 
 
Oral administration of NGN to obese Wistar 
albino rats at 50mg/kg and 100mg/kg produced 
significant saluretic activity, but did not result in  
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Table 3: Effect of NGN on urinary electrolyte excretion in normal and obese rats 
 
Parameter Control HFD-only HFD + NGN 
50 mg/kg 100 mg/kg 
Urinary Na+ (mmol/L) 85.8±6.35 43.2±3.21* 99.2±5.72# 110.2±6.67# 
Urinary K+ (mmol/L) 56.8±3.67 24.4±2.23* 67.4±4.35# 75.6±3.57# 
Urinary Cl- (mmol/L) 61.8±5.81 31.6±3.06* 67.8±4.33# 77.4±4.79# 
Na+ index 1.00 0.50 1.16 1.28 
K+ index 1.00 0.43 1.19 1.33 
Cl- index 1.00 0.51 1.10 1.25 
Results are expressed as mean ± SEM (n = 6). Index = excretion in test group / excretion in control group. 
*Significantly different, relative to control group (p < 0.05); #significantly different, relative to HFD-only group (p < 
0.05) 
 
Table 4: Effect of NGN on natriuretic activity, saluretic activity and CAI activities in normal and obese rats 
 
Parameter Control HFD-only HFD + NGN 
50 mg/ kg 100 mg/ kg 
Saluretic activity 147.6±8.55 74.8±3.89* 167.0±8.15# 187.6±8.87# 
Natriuretic activity 1.54±0.14 1.82±0.16 1.52±0.15 1.45±0.04 
CAI activity 0.44±0.05 0.49±0.07 0.41±0.03 0.42±0.03 
Saluretic Index 1.00 0.51 1.13 1.27 
Natriuretic Index 1.00 1.18 0.99 0.94 
CAI Index 1.00  1.11 0.93 0.95 
Results are expressed as mean ± SEM (n = 6). Index = excretion in test group / excretion in control group. 
*Significantly lower, relative to control group (p < 0.05); #significantly higher than corresponding value for HFD-
only group (p < 0.05). 
 





The World Health Organization (WHO) has 
defined obesity is an abnormal accumulation of 
adipose tissue which is detrimental to good 
health [16]. Increased lipid levels in blood are 
important risk factors for atherosclerosis, stroke 
and hypertension which are major health 
problems in developing countries. Studies have 
established an association between obesity and 
various co-morbidities such as hypertension, 
diabetes mellitus and dyslipidemia [17]. In the 
present study, the diuretic and anti-
hypercholesterolemic effect of NGN in HFD-
induced experimental obesity in Wistar albino 
rats was assessed. Obesity was induced by 
feeding high fat diet for 28 days, and confirmed 
by an increase in serum total cholesterol. 
 
Studies have indicated that excess intake of 
high-fat diet is not accompanied by a relative 
increase in its oxidation, leading to accumulation 
of more lipids in adipose tissue and an increase 
in body weight [18,19]. This is in agreement with 
the results obtained in the present study, where 
feeding of HFD to normal rats led to significant 
increases in serum cholesterol levels. 
Furthermore, analyses of urine samples from the 
rats fed HFD for 28 days revealed significant 
decreases in urinary volume and significant 
decreases in excretion of Na+, K+ and Cl-. It has 
been reported that obesity in rats is associated 
with some degree of impairment of urinary 
bladder function through decreased urodynamic 
pressure without disturbance of glucose 
metabolism [20,21]. 
 
In the present study, oral administration of NGN 
to obese rats at 50mg/kg and 100mg/kg for 28 
days produced anti-obesity and diuretic effects 
which were clearly evidenced by significant 
decreases in serum cholesterol levels and 
increased urinary volume. 
 
In a previous study, NGN ameliorated increases 
in plasma lipid levels in HFD–fed rats [22]. 
Increases in plasma and tissue cholesterol levels 
of ethanol-fed rats have been attributed to up-
regulation of HMG CoA reductase, the rate-
limiting enzyme in the biosynthetic pathway of 
cholesterol [23]. Studies have demonstrated the 
inhibitory effect of NGM (50mg/kg) administered 
along with ethanol, on the activity of HMG CoA 
reductase [24].  
 
The findings of the present study indicate dose-
dependent effect of NGN on urine excretion. 
Diuretic activity is considered to be good if 
diuretic index value is greater than 1.50, 
moderate for values between 1.00 and 1.50, mild 
if the values lie between 0.72 and 1.00, and 
absent if the value is less than 0.72 [25]. In 
present study, the diuretic index values of the 
NGN-treated groups (50 and 100 mg/kg) were 
1.83 and 2.19 (at 5h), and 1.71 and 2.39 (at 
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24h), respectively, indicating that NGN exhibited 
very good diuretic property especially at the 
higher dose of 100 mg/kg.  
 
In addition, the excretion of Na+, K+ and Cl- in 
urine of the obese rats treated with NGN was 
significantly increased, and there was slight 
alkalization of urine. Increased urinary Na+ 
excretion in the experimental animals after NGN 
administration is an indication of the potential of 
NGN as an antihypertensive agent [26]. 
 
Conductivity, an indirect index of urinary ion 
content, significantly decreased in the obese rats 
after administration of HFD for 28 days, but 




These results indicate that oral administration of 
NGN to hypercholesterolemic rats significantly 
mitigated increases in serum cholesterol, and 
produced significant diuretic effect. Thus, it can 
be reasonably suggested that NGN may be 
useful for the treatment of hypercholesterolemia 
associated with water and sodium retention. 
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